Lapatinib Completed Phase 2 Trials for Neoplasms, Gastrointestinal Tract Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00526669Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib